Toxin-induced mitochondrial dysfunction

International Review of Neurobiology

Volumn 53, Issue , 2002, Pages 243-279

  Browne, Susan E ^a   Flint Beal, M ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME C OXIDASE; MULTIENZYME COMPLEX; MYCOTOXIN; OXIDOREDUCTASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SUCCINATE DEHYDROGENASE; SUCCINATE DEHYDROGENASE (UBIQUINONE); TOXIN;

ANIMAL; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DRUG EFFECT; ENZYMOLOGY; HUMAN; METABOLISM; MITOCHONDRIAL MYOPATHY; MITOCHONDRION; REVIEW;

ANIMALS; DISEASE MODELS, ANIMAL; ELECTRON TRANSPORT COMPLEX I; ELECTRON TRANSPORT COMPLEX II; ELECTRON TRANSPORT COMPLEX IV; HUMANS; MITOCHONDRIA; MITOCHONDRIAL MYOPATHIES; MULTIENZYME COMPLEXES; MYCOTOXINS; NADH, NADPH OXIDOREDUCTASES; OXIDOREDUCTASES; SUCCINATE DEHYDROGENASE; TOXINS, BIOLOGICAL;

EID: 0036982566     PISSN: 00747742     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0074-7742(02)53010-5     Document Type: Review

References (217)

1. T. Aiuchi M. Matsunaga M. Syo K. Nakaya The relation between respiratory inhibition and uptake of 1-methyl-isoquinoline (MIQ+) in mitochondria Neurochem. Int. 28 1996 319 323
2. A. Albanese R. Granata B. Gregori M.P. Piccardi C. Colosimo P. Tonali Chronic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to monkeys: Behavioural, morphological and biochemical correlates Neuroscience 55 1993 823 832
3. R.L. Albin Basal ganglia neurotoxins Neurol Clin. 18 2000 665 680
4. R.L. Albin J.T. Greenamyre Alternative excitotoxic hypotheses Neurology 42 1992 733 738
5. T.A. Alston L. Mela H.J. Bright 3-Nitropropionate, the toxic substance of indigofera, is a suicide inactivator of succinate dehydrogenase Proc. Natl. Acad. Sci. USA 74 1977 3767 3771
6. O.A. Andreassen R.J. Ferrante A. Dedeoglu D.W. Albers P. Klivenyi E.J. Carlson C.J. Epstein M.F. Beal Mice with a partial deficiency of manganese superoxide dismutase show increased vulnerability to the mitochondrial toxins malonate, 3-nitropropionic acid, and MPTP Exp. Neurol. 167 2001 189 195
7. M.P. Armanini C. Hutchins B.A. Stein R.M. Sapolsky Glucocorticoid endangerment of hippocampal neurons is NMDA-receptor dependent Brain Res. 532 1990 7 12
8. C.D. Balaban Central neurotoxic effects of intraperitoneally administered 3-acetylpyridine, harmaline and niacinamide in Sprague-Dawley and Long-Evans rats: A critical review of central 3-acetylpyridine neurotoxicity Brain Res. 356 1985 21 42
9. K.S. Bankiewicz E.H. Oldfield C.C. Chiueh J.L. Doppman D.M. Jacobowitz I.J. Kopin Hemiparkinsonism in monkeys after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Life Sci. 39 1986 7 16
10. M.F. Beal Huntington's disease, energy, and excitotoxicity Neurobiol. Aging 15 1994 275 276
11. M.F. Beal Energetics in the pathogenesis of neurodegenerative diseases Trends Neurosci. 23 2000 294 300
12. M.F. Beal Experimental models of Parkinson's disease Nat. Rev. Neurosci. 2 2001 325 334
13. M.F. Beal R.J. Ferrante K.J. Swartz N.W. Kowall Chronic quinolinic acid lesions in rats closely resemble Huntington's disease J. Neurosci. 11 1991 1649 1659
14. 10 and nicotinamide block striatal lesions produced by the mitochondrial toxin malonate Ann. Neurol. 36 1994 882 888
15. M.F. Beal R.J. Ferrante R. Henshaw R.T. Matthews P.H. Chan N.W. Kowall C.J. Epstein J.B. Schulz 3-Nitropropionic acid neurotoxicity is attenuated in copper/zinc superoxide dismutase transgenic mice J. Neurochem. 65 1995 919 922
16. 10 attenuates the MPTP induced loss of striatal dopamine and dopaminergic axons in aged mice Brain Res. 783 1997 109 114
17. J.S. Beckman Oxidative damage and tyrosine nitration from peroxynitrite Chem. Res. Toxicol. 9 1996 836 844
18. A. Benazzouz T. Boraud P. Dubedat A. Boireau J.M. Stutzmann C. Gross Riluzole prevents MPTP-induced parkinsonism in the rhesus monkey: A pilot study Eur. J. Pharmacol. 284 1995 299 307
19. E. Benbrik P. Chariot S. Bonavaud M. Ammi-Said E. Frisdal C. Rea R. Gherardi G. Barlovatz-Meimon Cellular and mitochondrial toxicity of zidovudine (AZT), didanosine (ddI) and zalcitabine (ddC) on cultured human muscle cells J. Neurol. Sci. 149 1997 19 25
20. R. Betarbet T.B. Sherer G. MacKenzie M. Garcia-Osuna A.V. Panov J.T. Greenamyre Chronic systemic pesticide exposure reproduces features of Parkinson's disease Nature Neurosci. 3 2000 1301 1306
21. E. Bezard C.E. Gross M.C. Fournier S. Dovero B. Bloch M. Jaber Absence of MPTP-induced neuronal death in mice lacking the dopamine transporter Exp. Neurol. 155 1999 268 273
22. L.A. Bindhoff M. Birch-Machin N.E. Cartlidge W.D. Parker Jr. D.M. Turnbull Mitochondrial function in Parkinson's disease Lancet 2 1989 49
23. D. Blum S. Torch N. Lambeng M. Nissou A.L. Benabid R. Sadoul J.M. Verna Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: Contribution to the apoptotic theory in Parkinson's disease Prog. Neurobiol. 65 2001 135 172
24. I. Bodis-Wollner E. Chung M.F. Ghilardi A. Glover M. Onofrj P. Pasik Y. Samson Acetyl-levo-carnitine protects against MPTP-induced parkinsonism in primates J. Neurol. Transm. Park. Dis. Dement. Sect. 3 1991 63 72
25. A. Boireau P. Dubedat F. Bordier C. Peny J.M. Miquet G. Durand M. Meunier A. Doble Riluzole and experimental parkinsonism: Antagonism of MPTP-induced decrease in central dopamine levels in mice Neuroreport 5 1994 2657 2660
26. R. Borgohain A.K. Singh H. Radhakrishna V.C. Rao S. Mohandas Delayed onset generalized dystonia after cyanide poisoning Clin. Neurol. Neurosurg. 97 1995 213
27. 10 Neurology 38 1988 892 899
28. E. Brouillet M.F. Beal NMDA antagonists partially protect against MPTP induced neurotoxicity in mice Neuroreport 4 1993 387 390
29. E.P. Brouillet L. Shinobu U. McGarvey F. Hochberg M.F. Beal Manganese injection into the rat striatum produces excitotoxic lesions by impairing energy metabolism Exp. Neurol. 120 1993 89
30. E. Brouillet P. Hantraye R.J. Ferrante R. Dolan A. Leroy-Willig N.W. Kowall M.F. Beal Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates Proc. Natl. Acad. Sci. USA 92 1995 7105 7109
31. E. Brouillet M.C. Guyot V. Mittoux S. Altairac F. Condé S. Palfi P. Hantraye Partial inhibition of brain succinate deshydrogenase by 3-nitropropionic acid is sufficient to initiate striatal degeneration in rat J. Neurochem. 70 1998 794 805
32. E. Brouillet F. Conde M.F. Beal P. Hantraye Replicating Huntington's disease phenotype in experimental animals Prog. Neurobiol. 59 1999 427 468
33. S.E. Browne A.C. Bowling U. McGarvey M.J. Baik S.C. Berger M.K. Muqit E.D. Bird M.F. Beal Oxidative damage and metabolic dysfunction in Huntington's disease: Selective vulnerability of the basal ganglia Ann. Neurol. 41 1997 646 653
34. R.S. Burns C.C. Chiueh S.P. Markey M.H. Ebert D.M. Jacobowitz I.J. Kopin A primate model of parkinsonism: Selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Proc. Natl. Acad. Sci. USA 80 1983 4546 4550
35. S. Callier M. Morissette M. Grandbois T. Di Paolo Stereospecific prevention by 17-estradiol of MPTP-induced dopamine depletion in mice Synapse 37 2000 245 251
36. D.B. Calne J.W. Langston W.R. Martin A.J. Stoessl T.J. Ruth M.J. Adam B.D. Pate M. Schulzer Positron emission tomography after MPTP: Observations relating to the cause of Parkinson's disease Nature 317 1985 246
37. D.B. Calne N.S. Chu C.C. Huang C.S. Lu W. Olanow Manganism and idiopathic parkinsonism: Similarities and differences Neurology 44 1994 1583 1586
38. J.Y. Chang L.-Z. Liu Manganese potentiates nitric oxide production by microglia Mol. Brain Res. 68 1999 22
39. C.J. Coles D.E. Edmonson T.P. Singer Inactivation of succinate dehydrogenase by 3-nitropropionate J. Biol. Chem. 255 1979 4772 4780
40. C. Cosi M. Marien Decreases in mouse brain NAD+ and ATP induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): Prevention by the poly(ADP-ribose) polymerase inhibitor, benzamide Brain Res. 809 1998 58 67
41. J. Couper On the effects of black oxide of magnesium when inhaled into the lungs Br. Ann. Med. Pharmacol. 1 1837 41
42. 2+, on striatal and nigral synthesis and levels of dopamine and cofactor Neurotoxicol. Teratol. 13 1991 483
43. A.J. Daniels K. Gysling J. Abarca Uptake and release of manganese by rat striatal slices Biochem. Pharmacol. 30 1981 1833 1837
44. G.C. Davis A.C. Williams S.P. Markey M.H. Ebert E.D. Caine C.M. Reichert I.J. Kopin Chronic Parkinsonism secondary to intravenous injection of meperidine analogues Psychiatre Res. 1 1979 249 254
45. T. Dehmer J. Lindenau S. Haid J. Dichgans J.B. Schulz Deficiency of inducible nitric oxide synthase protects against MPTP toxicity in vivo J. Neurochem. 74 2000 2213 2216
46. D. Denny-Brown Neurological conditions resulting from prolonged and severe dietary restrictions Medicine 26 1947 41 48
47. J.C. Desclin J. Escubi Effects of 3-acetylpyridine on the central nervous system of the rat, as demonstrated by silver methods Brain Res. 77 1974 349 364
48. M.S. Desole G. Esposito L. Fresu R. Migheli P. Enrico M. Miele G. De Natale E. Miele Correlation between 1-methyl-4-phenylpyridinium ion (MPP+) levels, ascorbic acid oxidation and glutathione levels in the striatal synaptosomes of the 1-methyl-4-phenyl1,2,3,6-tetrahydropyridine (MPTP)-treated rat Neurosci. Lett. 161 1993 121 123
49. M.S. Desole L. Sciola M.R. Delogu S. Sircana R. Migheli E. Miele Role of oxidative stress in the manganese and 1-methyl-4-(2′-ethylphenyl)-1,2,3,6-tetrahydropyridine-induced apoptosis in PC12 cells Neurochem. Int. 31 1997 169 176
50. A.Y. Deutsch D.L. Rosin M. Goldstein R.H. Roth 3-Acetylpyridine-induced degeneration of the nigrostriatal dopamine system: An animal model of olivopontocerebellar atrophy-associated parkinsonism Exp. Neurol. 105 1989 1 9
51. D. Di Monte S.A. Jewell G. Ekstrom M.S. Sandy M.T. Smith MPTP and MPP+ cause rapid ATP depletion in isolated hepatocytes Biochem. Biophys. Res. Comm. 137 1986 310 315
52. Y. Du R.C. Dodel K.R. Bales R. Jemmersom E. Hamilton-Byrd S.M. Paul Involvement of a caspase-3-like cysteine protease in 1-methyl-4-phenylpyridinium-mediated apoptosis of cultured cerebellar granule neurons J. Neurochem. 69 1997 1382 1388
53. M. Ebadi P. Govitrapong S. Sharma D. Muralikrishnan S. Shavali L. Pellett R. Schafer C. Albano J. Eken Ubiquinone (coenzyme q10) and mitochondria in oxidative stress of parkinson's disease Biol. Signals Recept. 10 2001 224 253
54. O. Eberhardt R.V. Coelln S. Kugler J. Lindenau S. Rathke-Hartlieb E. Gerhardt S. Haid S. Isenmann C. Gravel A. Srinivasan M. Bahr M. Weller J. Dichgans J.B. Schulz Protection by synergistic effects of adenovirus-mediated X-chromosome-linked inhibitor of apoptosis and glial cell line-derived neurotrophic factor gene transfer in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease J. Neurosci. 20 2000 9126 9134
55. L. Ernster G. Dallner G.F. Azzone Differential effects of rotenone and amytal on mitochondrial electron and energy transfer J. Biol. Chem. 238 1963 1124 1131
56. B. Ferger P. Teismann C.D. Earl K. Kuschinsky W.H. Oertel Salicylate protects against MPTP-induced impairments in dopaminergic neurotransmission at the striatal and nigral level in mice Naunyn Schmiedebergs Arch. Pharmacol. 360 1999 256 261
57. R.J. Ferrante J.B. Schulz N.W. Kowall M.F. Beal Systemic administration of rotenone produces selective damage in the striatum and globus pallidus, but not in the substantia nigra Brain Res. 753 1997 157 162
58. R.J. Ferrante O.A. Andreassen B.G. Jenkins A. Dedeoglu S. Kuemmerle J.K. Kubilus R. Kaddurah-Daouk S.M. Hersch M.F. Beal Neuroprotective effects of creatine in a transgenic mouse model of Huntington's disease J. Neurosci. 20 2000 4389 4397
59. L.S. Forno J.W. Langston L.E. DeLanney I. Irwin G.A. Ricaurte Locus ceruleus lesions and eosinophilic inclusions in MPTP-treated monkeys Ann. Neurol. 20 1986 449 455
60. S. Genc E. Kuralay K. Genc M. Akhisaroglu S. Fadiloglu K. Yorukoglu M. Fadiloglu A. Gure Erythropoietin exerts neuroprotection in 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-treated C57/BL mice via increasing nitric oxide production Neurosci. Lett. 298 2001 139 141
61. M. Gerlach P. Riederer Animal models of Parkinson's disease: An empirical comparison with the phenomenology of the disease in man J. Neural Transm. 103 1996 987 1041
62. B.I. Giasson J.E. Duda I.V. Murray Q. Chen J.M. Souza H.I. Hurtig H. Ischiropoulos J.Q. Trojanowski V.M. Lee Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions Science 290 2000 985 989
63. M. Gonzalez-Zulueta L.M. Ensz G. Mukhina R.M. Lebovitz R.M. Zwacka J.E. Engelhardt L.W. Oberley V.L. Dawson T.M. Dawson Manganese superoxide dismutase protects nNOS neurons from NMDA and nitric oxide-mediated neurotoxicity J. Neurosci. 18 1998 2040 2055
64. P.E. Good A. Hsu P. Werner D.P. Perl C.W. Olanow Protein nitration in Parkinson's disease J. Neuropathol. Exp. Neurol. 57 1998 338 339
65. J.M. Gorell C.C. Johnson B.A. Rybicki E.L. Peterson R.J. Richardson The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living Neurology 50 1998 1346 1350
66. D.H. Gould D.L. Gustine Basal ganglia degeneration, myelin alterations, enzyme inhibition induced in ice by the plant toxin 3-nitropropionic acid Neuropathol. Appl. Neurobiol. 8 1982 377 393
67. H. Gould M.P. Wilson D.W. Hamar Brain enzyme and clinical alterations induced in rats and mice by nitroaliphatic toxicants Tox. Lett. 27 1985 83 89
68. M. Gu M.T. Gash V.M. Mann F. Javoy-Agid J.M. Cooper A.H. Shapira Mitochondrial defect in Huntington's disease caudate nucleus Ann. Neurol. 39 1996 385 389
69. M. Gutman T.P. Singer J.E. Casida Studies on the respiratory chain-linked reduced nicotinamide adenine dinucleotide dehydrogenase. XVII. Reaction sites of piericidin A and rotenone J. Biol. Chem. 245 1970 1992 1997
70. G. Hageman J. van der Hoek M. van Hout G. van der Laan E.J. Steur W. de Bruin K. Herholz Parkinsonism, pyramidal signs, polyneuropathy, and cognitive decline after long-term occupational solvent exposure J. Neurol. 246 1999 198 206
71. B.F. Hamilton D.H. Gould Nature and distribution of brain lesions in rats intoxicated with 3-nitropropionic acid: A type of hypoxic (energy deficient) brain damage Acta Neuropathol. (Berlin) 72 1987 286 297
72. P. Hantraye E. Brouillet R. Ferrante S. Palfi R. Dolan R.T. Matthews M.F. Beal Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons Nature Med. 2 1996 1017 1021
73. A. Haque M. Hossain G. Wouters F. Lambein Epidemiological study of lathyrism in northwestern districts of Bangladesh Neuroepidemiology 15 1996 83 91
74. A. Hartmann S. Hunot P.P. Michel M.P. Muriel S. Vyas B.A. Faucheux A. Mouatt-Prigent H. Turmel A. Srinivasan M. Ruberg G.I. Evan Y. Agid E.C. Hirsch Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease Proc. Natl. Acad. Sci. USA 97 2000 2875 2880
75. F. He S. Zhang F. Qian C. Zhang Delayed dystonia with striatal CT lucencies induced by a mycotoxin (3-nitropropionic acid) Neurology 45 1995 2178 2183
76. R.E. Heikkila W.J. Nicklas I. Vyas R.C. Duvoisin Dopaminergic toxicity of rotenone and the 1-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: Implication for the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity Neurosci. Lett. 62 1985 389 394
77. K. Hensley Q.N. Pye M.L. Maidt C.A. Stewart K.A. Robinson F. Jaffrey R.A. Floyd Interaction of alpha-phenyl-N-tert butyl nitrone and alternative electron acceptors with complex I indicates a substrate reduction site upstream from the rotenone binding site J. Neurochem. 71 1998 2549 2557
78. H. Herken Functional disorders of the brain induced by synthesis of nucleotides containing 3-acetylpyridine Z. Klin. Chem. Kin. Biochem. 6 1968 357 367
79. S.P. Hicks Brain metabolism in vivo I Arch. Pathol. 49 1950 111 137
80. S.P Hicks Brain metabolism in vivo II Arch. Pathol. 50 1950 545 561
81. 3H] Dihydrorotenone binding to NADH: Ubiquinone reductase (complex I) of the electron transport chain: an autoradiographic study J. Neurosci. 16 1996 3807 3816
82. Y. Hirata K. Kiuchi T. Nagatsu Manganese mimics the action of 1-methyl-4 phenylpyridinium ion, a dopaminergic neurotoxin, in rat striatal tissue slices Neurosci. Lett. 311 2001 53 56
83. D.J. Horgan T.P. Singer J.E. Casida Studies on the respiratory chain-linked reduced nicotinamide adenine dinucleotide dehydrogenase: 13. Binding sites of rotenone, piericidin A, and amytal in the respiratory chain J. Biol. Chem. 243 1968 834 843
84. L.J. Hsu Y. Sagara A. Arroyo E. Rockenstein A. Sisk M. Mallory J. Wong T. Takenouchi M. Hashimoto E. Masliah α-Synuclein promotes mitochondrial deficit and oxidative stress Am. J Pathol. 157 2000 401 410
85. C.C. Huang C.C. Chu R.S. Chen S.K. Lin T.S. Shih Chronic carbon disulfide encephalopathy Eur. Neurol. 36 1996 364 368
86. C.C. Huang N.S. Chu C.S. Lu R.S. Chen D.B. Calne Long-term progression in chronic manganism: Ten years of follow-up Neurology 50 1998 698 700
87. 10 and idebenone J. Neurol. Sci. 90 1989 263 271
88. S. Inagaki H. Takagi K. Suzuki F. Akai N. Taniguchi Intense immunoreactivity for Mn-superoxide dismutase (Mn-SOD) in cholinergic and non-cholinergic neurons in the rat basal forebrain Brain Res. 541 1991 354 357
89. I. Irwin J.W. Langston The selective accumulation of MPP+ in the substantia nigra: A key to neurotoxicity? Life Sci. 36 1995 207 212
90. Y. Itano Y. Nomura 1-Methyl-4-phenylpyridinium ion (MPP+) causes DNA fragmentation and increases the Bcl-2 expression in human neuroblastoma, SH-SY5Y cells through different mechanisms Brain Res. 704 1995 240 245
91. C. Jay M. Ropka M. Dalakas The drugs 2,3-dideoxyinosine (ddI) and 2,3-dideoxycytidine (ddC) are safe alternatives in people with AIDS with zidovudine-induced myopathy J. AIDS 7 1994 630 631
92. B.G. Jenkins W. Koroshetz M.E. Beal B. Rosen Evidence for an energy metabolism defect in Huntington's disease using localized proton spectroscopy Neurology 43 1993 2689 2695
93. W.P. Kerns M.A. Kirk Cyanide and hydrogen sulfide Goldfrank's Toxicologic Emergencies 6th ed. 1998 1567
94. U. Khan B. Filiano M.P. King S. Przedborski Is Parkinson's disease (PD) an extra-mitochondrial disorder? Neurology 48 1997 A201
95. T. Kitada S. Asakawa N. Hattori H. Matsumine Y. Yamamura S. Minoshima M. Yokochi Y. Mizuno N. Shimizu Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism Nature 392 1998 605 608
96. Y. Kitamura T. Kosaka J.L. Kakimura Y. Matsuoka Y. Kohno Y. Nomura T. Taniguchi Protective effects of the antiparkinsonian drugs talipexole and pramipexole against 1-methyl-4-phenylpyridinium-induced apoptotic death in human neuroblastoma SH-SY5Y cells Mol. Pharmacol. 54 1998 1046 1054
97. P.St. Klivenyi D. Clair M. Wermer H.C. Yen T. Oberley L. Yang M.F. Beal Manganese superoxide dismutase overexpression attenuates MPTP toxicity Neurobiol. Dis. 5 1998 253 258
98. P. Klivenyi M.F. Beal R.J. Ferrante O.A. Andreassen M. Wermer M.R. Chin J.V. Bonventre Mice deficient in group IV cytosolic phospholipase A2 are resistant to MPTP neurotoxicity J. Neurochem. 71 1998 2634 2637
99. P. Klivenyi R.J. Ferrante R.T. Matthews M.B. Bogdanov A.M. Klein O.A. Andreassen G. Mueller M. Wermer R. Kaddurah-Daouk M.F. Beal Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis Nature Med. 5 1999 347 350
100. P. Klivenyi O.A. Andreassen R.J. Ferrante E. Lancelot D. Reif M.F. Beal Inhibition of neuronal nitric oxide synthase protects against MPTP toxicity Neuroreport 11 2000 1265 1268
101. P. Klivenyi O.A. Andreassen R.J. Ferrante A. Dedeoglu G. Mueller E. Lancelot M. Bogdanov J.K. Andersen D. Jiang M.F. Beal Mice deficient in cellular glutathione peroxidase show increased vulnerability to malonate, 3-nitropropionic acid, and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine J. Neurosci. 20 2000 1 7
102. S. Környey Patterns of CNS vulnerability in CO, cyanide and other poisoning J.P. Schadé W.H. McMenemey Selective vulnerability of the brain in hypoxaemia 1963 Blackwell Oxford 165 176
103. W. Korohoda Z. Pietrzkowski K. Reiss Chloramphenicol, an inhibitor of mitochondrial protein synthesis, inhibits myoblast fusion and myotube differentiation Folia Histochem. Cytobiol. 31 1993 9 13
104. 10 Ann. Neurol. 41 1997 160 165
105. N.W. Kowall P. Hantraye E. Brouillet M.F. Beal A.C. McKee R.J. Ferrante MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons Neuroreport 11 2000 211 213
106. T. Kristian G. Gido B.K. Siesjo The influence of acidosis on hypoglycemic brain damage J. Cereb. Blood Flora Metab. 15 1995 78 87
107. G. Kunig J. Hartmann B. Niedermeyer J. Deckert G. Ransmayr H. Heinsen H. Beckmann P. Riederer Excitotoxins l -beta-oxalyl-amino-alanine ( l -BOAA) and 3,4,6-trihydroxyphenylalanine (6-OH-DOPA) inhibit [3H] alpha-amino-3-hydroxy-rrmethyl-4-isoxazole-propionic acid (AMPA) binding in human hippocampus Neurosci. Lett. 169 1994 219 222
108. I. Kurkowska-Jastrzebska A. Wronska M. Kohutnicka A. Czlonkowski A. Czlonkowska The inflammatory reaction following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxication in mouse Exp. Neurol. 156 1999 50 61
109. J.W. Langston P. Ballard J.W. Tetrud I. Irwin Chronic Parkinsonism in human due to a product of meperidine-analog synthesis Science 219 1983 979 980
110. J.W. Langston L.S. Forno J. Tetrud A.G. Reeves J.A. Kaplan D. Karluk Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure Ann. Neurol. 46 1999 598 605
111. M. Lee D.H. Hyun B. Halliwell P. Jenner Effect of the overexpression of wild-type or mutant α-synuclein on cell susceptibility to insult J. Neurochem. 76 2001 998 1009
112. G.T. Liberatore V. Jackson-Lewis S. Vukosavic A.S. Mandir M. Vila W.G. McAuliffe V.L. Dawson T.M. Dawson S. Przedborski Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease Nature Med. 5 1999 1403 1409
113. A. Lista J. Abarca C. Ramos A.J. Daniels Rat striatal dopamine and tetrahydrobiopterin content following an intrastriatal injection of manganese chloride Life Sci. 38 1986 2121 2127
114. R. Lodi P.E. Hart B. Rajagopalan D.J. Taylor J.G. Crilley J.L. Bradley A.M. Blamire D. Manners P. Styles A.H. Schapira J.M. Cooper Antioxidant treatment improves in vivo cardiac and skeletal muscle bioenergetics in patients with Friedreich's ataxia Ann. Neurol. 49 2001 590 596
115. L.A. Love F.W. Miller Noninfectious environmental agents associated with myopathies Curr Opin. Rheumatol. 5 1993 712 718
116. C.S. Lu C.C. Huang N.S. Chu D.B. Calne Levodopa failure in chronic manganism Neurology 44 1994 1600
117. A.C. Ludolph F. He P.S. Spencer J. Hammerstad M. Sabri 3-Nitroproprionic acid-exogenous animal neurotoxin and possible human striatal toxin Can. J. Neurol. Sci. 18 1991 492 498
118. C. Malcon R. Kaddurah-Daouk M.F. Beal Neuroprotective effects of creatine administration against NMDA and malonate toxicity Brain Res. 860 2000 195 198
119. V.M. Mann J.M. Cooper D. Krige S.E. Daniel A.H. Schapira C.D. Marsden Brain, skeletal-muscle and platelet homogenate mitochondrial function in Parkinson's disease Brain 115 1992 333 342
120. R.T. Matthews M.F. Beal J. Fallon K. Fedorchak P.L. Huang M.C. Fishman B.T. Hyman MPP+ induced substantia nigra degeneration is attenuated in nNOS knockout mice Neurobiol. Dis. 4 1997 114 121
121. R.T. Matthews L. Yang B.G. Jenkins R.J. Ferrante B.R. Rosen R. Kaddurah-Daouk M.F. Beal Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's disease J. Neurosci. 18 1998 156 163
122. R.T. Matthews P. Klivenyi G. Mueller L. Yang M. Wermer C.E. Thomas M.F. Beal Novel free radical spin traps protect against malonate and MPTP neurotoxicity Exp. Neurol. 157 1999 120 126
123. K.S. McNaught P.A. Carrupt C. Altomare S. Cellamare A. Carotti B. Testa P. Jenner C.D. Marsden Isoquinoline derivatives as endogenous neurotoxins in the aetiology of Parkinson's disease Biochem Pharmacol. 56 1998 921 933
124. B. Melegh K. Trombitas Valproate treatment induces lipid globule accumulation with ultrastructural abnormalities of mitochondria in skeletal muscle Neuropediatrics 28 1997 257 261
125. A. Menegon P.G. Board A.C. Blackburn G.D. Mellick D.G. Le Couteur Parkinson's disease, pesticides, and glutathione transferase polymorphisms Lancet 352 1998 1344 1346
126. K. Miyoshi Experimental striatal necrosis induced by sodium azide. A contribution to the problem of selective vulnerability and histochemical studies of enzymatic activity Acta Neuropathol. (Berl). 9 1967 199 216
127. Y. Mizuno S. Ohta M. Tanaka S. Takamiya K. Suzuki T. Sato H. Oya T. Ozawa Y. Kagawa Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease Biochem. Biophys. Res. Commun. 163 1989 1450 1455
128. H. Mochizuki N. Nakamura K. Nishi Y. Mizuno Apoptosis is induced by 1-methyl-4-phenylpyridinium ion (MPP+) in ventral mesencephalic-striatal co-colture in rat Neurosci. Lett. 170 1994 191 194
129. K.P. Mohanakumar D. Muralikrishnan B. Thomas Neuroprotection by sodium salicylate against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity Brain Res. 864 2000 281 290
130. S. Moussaoui M.C. Obinu N. Daniel M. Reibaud V. Blanchard A. Imperato The antioxidant ebselen prevents neurotoxicity and clinical symptoms in a primate model of Parkinson's disease Exp. Neurol. 166 2000 235 245
131. D. Muralikrishnan K.P. Mohanakumar Neuroprotection by bromocriptine against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice FASEB J. 12 1998 905 912
132. S.J. Mustafa S.V. Chandra Levels of 5-hydroxytryptamine, dopamine and norepinephrine in whole brain of rabbits in chronic manganese toxicity J. Neurochem. 18 1971 931 933
133. T. Mutoh A. Tokuda A.M. Marini N. Fujiki 1-Methyl-4-phenylpyridinium kills differentiated PC12 cells with a concomitant change in protein phosphorylation Brain Res. 661 1994 51 55
134. N.H. Neff R.E. Barrett E. Costa Selective depletion of caudate nucleus dopamine and serotonin during chronic manganese dioxide administration to squirrel monkeys Experientia 25 1969 1140 1141
135. M.C. Newland T.L. Ceckler J.H. Kordower B. Weiss Visualizing manganese in the primate basal ganglia with magnetic resonance imaging Exp. Neurol. 106 1989 251
136. W.J. Nicklas L. Vyas R.E. Heikkila Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine Life Sci. 36 1985 2503 2508
137. A. Nicotra S.H. Parvez Cell death induced by MPTP, a substrate for monoamine oxidase B Toxicology 153 2000 157 166
138. A. Novelli J.A. Reilly P.G. Lysko R.C. Henneberry Glutamate becomes neurotoxic via the N-methyl- d -aspartate receptor when intracellular energy levels are reduced Brain Res. 451 1988 205 212
139. D. Offen P.M. Beart N.S. Cheung C.J. Pascoe A. Hochman S. Gorodin E. Melamed R. Bernard O. Bernard Transgenic mice expressing human Bcl-2 in their neurons are resistant to 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity Proc. Natl. Acad. Sci. USA 95 1998 5789 5794
140. Y.J. Oh S.C. Wong M. Moffat K.L. O'Malley Overexpression of Bcl-2 attenuates MPP+ but not 6-ODHA, induced cell death in a dopaminergic neuronal cell line Neurobiol. Dis. 2 1995 157 167
141. C.W. Olanow W.G. Tatton Etiology and pathogenesis of Parkinson's disease Ann. Rev. Neurosci. 22 1999 123 144
142. C.W. Olanow P.F. Good H. Shinotoh K.A. Hewitt E. Vingerhoets B.J. Snow M.F. Beal D.B. Calne D.P. Perl Manganese intoxication in the rhesus monkey: A clinical, imaging, pathologic, and biochemical study Neurology 46 1996 492
143. K.S. Pai V. Ravindranath l -BOAA induces selective inhibition of brain mitochondrial enzyme, NADH-dehydrogenase Brain Res. 621 1993 215 221
144. P.K. Pal A. Samii D.B. Calne Manganese neurotoxicity: A review of clinical features, imaging and pathology Neurotoxicology 20 1999 227 238
145. W.D. Parker Jr. S.J. Boyson J.K. Parks Abnormalities of the electron transport chain in idiopathic Parkinson's disease Ann. Neurol. 26 1989 719 723
146. E. Pedrol E. Masanes J. Fernandez-Sola M. Cofan J. Casademont J.M. Grau A. Urbano-Marquez Lack of muscle toxicity with didanosine (ddI): Clinical and experimental studies J. Neurol. Sci. 138 1996 42 48
147. S. Pennathur V. Jackson-Lewis S. Przedborski J.W. Heinecke Mass spectrometric quantification of 3-nitrotyrosine, ortho-tyrosine, and o,o′-dityrosine in brain tissue of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice, a model of oxidative stress in Parkinson's disease J. Biol. Chem. 274 1999 34621 34628
148. A. Pentschew F.F. Ebner R.M. Kovatch Experimental manganese encephalopathy in monkeys: A preliminary report J. Neuropathol. Exp. Neurol. 22 1962 488
149. S. Przedborski V. Jackson-Lewis Mechanisms of MPTP toxicity Mov. Disord. 13 1998 35 38
150. S. Przedborski V. Kostic V. Jackson-Lewis A.B. Naini S. Simonetti S. Fahn E. Carlson C.J. Epstein J.L. Cadet Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity J. Neurosci. 12 1992 1658 1667
151. S. Przedborski Q. Chen M. Vila B.L. Giasson R. Djaldatti S. Vukosavic J.M. Souza V.V. Jackson-Lewis V.M. Lee H. Ischiropoulos Oxidative post-translational modifications of α-synuclein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease J. Neurochem. 76 2001 637 640
152. E. Rosenow K. Herholz H. Lanfermann G. Weuthen R. Ebner J. Kessler M. Ghaemi W.D. Heiss Neurological sequelae of cyanide intoxication: The patterns of clinical, magnetic resonance imaging, and positron emission tomography findings Ann. Neurol. 38 1995 825
153. S.M. Ross P.S. Spencer Specific antagonism of behavioral action of “uncommon” amino acids linked to motor-system diseases Synapse 1 1987 248 253
154. Z.L. Rossetti A. Sotgiu D.E. Sharp M. Hadjiconstantinou N.H. Neff 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and free radicals in vitro Biochem. Pharmacol. 37 1988 4573 4574
155. M. Santiago A. Machado J. Cano Nigral and striatal comparative study of the neurotoxic action of 1-methyl-4-phenyl-pyridinium ion: Involvement of dopamine uptake system J. Neurochem. 66 1996 1182 1190
156. M.S. Saporito E.M. Brown M.S. Miller S. Carswell CEP-1347/KT-7515, an inhibitor of c jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons in vivo J. Pharmacol. Exp. Ther. 288 1999 421 427
157. M.S. Saporito B.A. Thomas R.W. Scott MPTP activates c-Jun NH(2)-terminal kinase (JNK) and its upstream regulatory kinase MKK4 in nigrostriatal neurons in vivo J. Neurochem. 75 2000 1200 1208
158. L.M. Sayre Biochemical mechanism of action of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Toxicol. Lett. 48 1989 121 149
159. A.H. Schapira J.M. Cooper D. Dexter J.B. Clark P. Jenner C.D. Marsden Mitochondrial complex I deficiency in Parkinson's disease J. Neurochem. 54 1990 823 827
160. E. Schuler T. Yano S. Di Bernardo T. Yagi V. Yankovskaya T.P. Singer J.E. Casida NADH-quinone oxidoreductase: PSST subunit couples electron transfer from iron-sulfur cluster N2 to quinone Proc. Natl. Acad. Sci. USA 96 1999 4149 4153
161. J.B. Schulz D.R. Henshaw B.G. Jenkins R.J. Ferrante N.W. Kowall B.R. Rosen M.F. Beal 3-Acetylpyridine produces age-dependent excitotoxic lesions in rat striatum J. Cereb. Blood Flow Metab. 14 1994 1024 1029
162. J.B. Schulz D.R. Henshaw R.T. Matthews M.E. Beal Coenzyme Q10 and nicotinamide and a free radical spin trap protect against MPTP neurotoxicity Exp. Neurol. 132 1995 279 283
163. J.B. Schulz R.T. Matthews M.M.K. Muqit S.E. Browne M.F. Beal Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice J. Neurochem. 64 1995 936 939
164. J.B. Schulz D.R. Henshaw D. Siwek B.G. Jenkins R.J. Ferrante P.B. Cipolloni N.W. Kowall B.R. Rosen M.F. Beal Involvement of free radicals in excitotoxicity in vivo J. Neurochem. 64 1995 2239 2247
165. J.B. Schulz R.T. Matthews D.R. Henshaw M.F. Beal Neuroprotective strategies for treatment of lesions produced by mitochondrial toxins: Implications for neurodegenerative diseases Neuroscience 71 1996 1043 1048
166. J.B. Schulz D.R. Henshaw U. MacGarvey M.F. Beal Involvement of oxidative stress in 3-nitropropionic acid neurotoxicity Neurochem. Intl. 29 1996 167 171
167. T.A. Seaton J.M. Cooper A.H. Schapira Free radical scavengers protect dopaminergic cell lines from apoptosis induced by complex I inhibitors Brain Res. 777 1997 110 118
168. M. Semino-Mora M. Leon-Monzon M. Dalakas The effect of l -carnitine on the AZT induced destruction of human myotubes. Part II: Treatment with l -carnitine improves the AZT-induced changes and prevents further destruction Lab. Invest. 71 1994 773 781
169. V.H. Sethy H. Wu J.A. Oostveen E.D. Hall Neuroprotective effects of the pyrrolopyrimidine U-104067F in 3-acetylpyridine-treated rats Exp. Neurol. 140 1996 79 83
170. V.H. Sethy H. Wu J.A. Oostveen E.D. Hall Neuroprotective effects of the GABA(A) receptor partial agonist U-101017 in 3-acetylpyridine-treated rats Neurosci. Lett. 228 1997 45 49
171. V.H. Sethy H. Wu J.A. Oostveen E.D. Hall Neuroprotective effects of the dopamine agonists pramipexole and bromocriptine in 3-acetylpyridine-treated rats Brain Res. 754 1997 181 186
172. J. Seyfried E. Soldner W.S. Kunz J.B. Schulz T. Klockgether K.A. Kovar U. Wüllner Effect of 1-methyl-4-phenylpyridinium on glutathione in rat pheochromocytoma PC 12 cells Neurochem. Int. 36 2000 489 497
173. J.P. Sheehan P.E. Palmer G.A. Helm J.B. Tuttle MPP+ induced apoptotic cell death in SH-SY5Y neuroblastoma cells: An electron microscope study J. Neurosci. Res. 48 1997 226 237
174. T.B. Sherer P.A. Trimmer K. Borland J.K. Parks J.P. Bennett Jr. J.B. Tuttle Chronic reduction in complex I function alters calcium signaling in SH-SY5Y neuroblastoma cells Brain Res. 891 2001 94 105
175. H. Shibasaki Electron microscope study of the rat brain with experimental sodium azide intoxication Acta Neuropathol (Berl). 14 1969 185 193
176. C.W. Shults R.H. Haas D. Passov M.E. Beal Coenzyme Q10 is reduced in mitochondria from parkinsonian patients Ann. Neurol. 42 1997 261 264
177. W.N. Sloot A.J. van der Sluijs-Gelling J.B.P. Gramsberger Selective lesions by manganese and extensive damage by iron after injection in rat striatum or hippocampus J. Neurochem. 62 1994 205
178. J.W. Snyder E.R. Safir G.P. Summerville Occupational fatality and persistent neurological sequelae after mass exposure to hydrogen sulfide Am. J. Emerg. Med. 13 1995 199
179. E. Soldner M. Weller S. Haid S. Beinroth S.W. Miller U. Wüllner R.E. Davis J. Dichgans T. Klockgether J.B. Schulz MPP+ inhibits proliferation of PC12 cells by a p21WAF1/Cip1-dependent pathway and induces cell death in cells lacking p21WAF1/Cip1 Exp. Cell Res. 250 1999 75 85
180. P.S. Spencer Lathyrism P.J. Vinken G.W. Bruyn Handbook of Clinical Neurology 1995 Elsevier Amsterdam 1 20
181. P.S. Spencer D.N. Roy A. Ludolph J. Hugon M.P. Dwivedi H.H. Schaumburg Lathyrism: Evidence for role of the neuroexcitatory aminoacid BOAA Lancet 2 1986 1066 1067
182. P.S. Spencer P.B. Nunn J. Hugon A.C. Ludolph S.M. Ross D.N. Roy R.C. Robertson Guam amyotrophic lateral sclerosis-parkinsonism-dementia linked to a plant excitant neurotoxin Science 237 1987 517 522
183. M. Spranger S. Schwab S. Desiderato E. Bonmann D. Krieger J. Fandrey Manganese augments nitric oxide synthesis in murine astrocytes: A new pathogenetic mechanism in manganism? Exp. Neurol. 149 1998 277
184. K. Sriram S.K. Shankar M.R. Boyd V. Ravindranath Thiol oxidation and loss of mitochondrial complex 1 precede excitatory amino acid-mediated neurodegeneration J. Neurosci. 18 1998 10287 10296
185. J.P. Steiner G.S. Hamilton D.T. Ross H.L. Valentine H. Guo M.A. Connolly S. Liang C. Ramsey J.H. Li W. Huang P. Howorth R. Soni M. Fuller H. Sauer A.C. Nowomik P.D. Suzdak Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal models Proc. Natl Acad. Sci. USA 94 1997 2019 2024
186. A. Storch A.C. Ludolph J. Schwarz HEK293 cells expressing the human dopamine transporter are susceptible to low concentrations of 1-methyl-4-phenylpyridine (MPP+) via impairment of energy metabolism Neurochem. Int. 35 1999 393 403
187. R.H. Swerdlow J.K. Parks J.N. Davis 2nd D.S. Cassarino P.A. Trimmer L.J. Currie J. Dougherty W.S. Bridges J.P. Bennett Jr. G.F. Wooten W.D. Parker Matrilineal inheritance of complex I dysfunction in a multigenerational Parkinson's disease family Ann. Neurol. 44 1998 873 881
188. A.H. Tahar A. Ekesbo L. Gregoire E. Bangassoro K.A. Svensson J. Tedroff P.J. Bedard Effects of acute and repeated treatment with a novel dopamine D2 receptor ligand on l -DOPA-induced dyskinesias in MPTP monkeys Eur. J. Pharmacol. 412 2001 247 254
189. M. Takada T. Kono 3-Acetylpyridine neurotoxicity to the nigrostriatal dopamine system in mice Neurosci. Lett. 161 1993 211 214
190. N. Takahashi L.L. Miner L. Sora H. Ujike R.S. Revay V. Kostic V. Jackson-Lewis S. Przedborski G.R. Uhl VMAT2 knockout mice: heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity Proc. Natl. Acad. Sci. USA 94 1997 9938 9943
191. M.A. Tarnopolsky M.F. Beal Potential for creatine and other therapies targeting cellular energy dysfunction in neurological disorders Ann. Neurol. 49 2001 561 574
192. N.A. Tatton Increased caspase 3 and Bax immunoreactivity accompany nuclear GAPDH translocation and neuronal apoptosis in Parkinson's disease Exp. Neurol. 166 2000 29 43
193. N.A. Tatton S.J. Kish In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining Neuroscience 77 1997 1037 1048
194. E. Teismann B. Ferger Inhibition of the cyclooxygenase isoenzymes COX-1 and COX-2 provide neuroprotection in the MPTP-mouse model of Parkinson's disease Synapse 39 2001 167 174
195. K.F. Tipton T.P. Singer Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds J. Neurochem. 61 1993 1191 1206
196. S.A. Treseder L.A. Smith P. Jenner Endogenous dopaminergic tone and dopamine agonist action Mov. Disord. 15 2000 804 812
197. P.A. Trimmer T.S. Smith A.B. Jung J.P. Bennett Jr. Dopamine neurons from transgenic mice with a knockout of the p53 gene resist MPTP neurotoxicity Neurodegeneration 5 1996 233 239
198. B. Tvedt K. Skyberg O. Aaserud A. Hobbesland T. Mathiesen Brain damage caused by hydrogen sulfide: A follow-up study of six patients Am. J. Indust. Med. 20 1991 91
199. R.J. Uitti A.H. Rajput E.M. Ashenhurst B. Rozdilsky Cyanide-induced Parkinsonism: A clinicopathologic report Neurology 35 1985 921
200. M. Varastet D. Riche M. Maziere P. Hantraye Chronic MPTP treatment reproduces in baboons the differential vulnerability of mesencephalic dopaminergic neurons observed in Parkinson's disease Neuroscience 63 1994 47 56
201. M. Vila S. Vukosavic V. Jackson-Lewis M. Neystat M. Jakowec S. Przedborski α-Synuclein upregulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP J. Neurochem. 74 2000 721 729
202. M. Vila V. Jackson-Lewis S. Vukosavic R. Djaldetti G. Liberatore D. Offen S.J. Korsmeyer S. Przedborski Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease Proc. Natl. Acad. Sci. USA 98 2001 2837 2842
203. P.C. Waldmeier W.P. Spooren B. Hengerer CGP 3466 protects dopaminergic neurons in lesion models of Parkinson's disease Naunyn Schmiedebergs Arch. Pharmacol. 362 2000 526 537
204. M. Weller A.M. Marini S.M. Paul Niacinamide blocks 3-acetylpyridine toxicity of cerebellar granule cells in vitro Brain Res. 594 1992 160 164
205. S. Wieland M.S. Kreider P. McGonigle I. Lucki Destruction of the nucleus raphe obscurus and potentiation of serotonin-mediated behaviors following administration of the neurotoxin 3-acetylpyridine Brain Res. 520 1990 291 302
206. C.L. Willis B.S. Meldrum P.B. Nunn B.H. Anderton P.N. Leigh Neuronal damage induced by beta-N-oxalylamino- l -alanine, in the rat hippocampus, can be prevented by a non-NMDA antagonist, 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo (F) quinoxaline Brain Res. 627 1993 55 62
207. C.L. Willis B.S. Meldrum P.B. Nunn B.H. Anderton P.N. Leigh Neuroprotective effect of free radical scavengers on beta-N-oxalylamino- l -alanine (BOAA)-induced neuronal damage in rat hippocampus Neurosci. Lett. 182 1994 159 162
208. E.C. Wolters C.C. Huang C. Clark R.F. Peppard J. Okada N.S. Chu M.J. Adam T.J. Ruth D. Li D.B. Calne Positron emission tomography in manganese intoxication Ann. Neurol. 26 1989 647
209. U. Wüllner A. Young J. Penney M.F. Beal 3-Nitropropionic acid toxicity in the striatum J. Neurochem. 63 1994 1772 1781
210. U. Wüllner P.A. Loschmann J.B. Schulz A. Schmid R. Dringen F. Eblen L. Turski T. Klockgether Glutathione depletion potentiates MPTP and MPP+ toxicity in nigral dopaminergic neurones Neuroreport 7 1996 921 923
211. M. Yamada S. Ohno I. Okayasu R. Okeda S. Hatakeyama H. Watanabe K. Ushio H. Tsukagoshi Chronic manganese poisoning: A neuropathological study with determination of manganese distribution in the brain Acta Neurapathol. (Berlin) 70 1986 273
212. L. Yang R.T. Matthews J.B. Schulz T. Klockgether A.W. Liao J.C. Martinou J.B. Penney Jr. B.T. Hyman M.F. Beal 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyride neurotoxicity is attenuated in mice overexpressing Bcl-2 J. Neurosci. 18 1998 8145 8152
213. M. Zedda F. Acone R. Panu V. Farina L. Sanna G. Palmieri Neurotoxic effects of 3-acetylpyridine (3-AP) in the hamster (mesocricetus auratus) Ital. J. Anat. Embryol. 101 1996 57 66
214. G.D. Zeevalk W.J. Nicklas Mechanisms underlying initiation of excitotoxicity associated with metabolic inhibition J. Pharm. Exp. Ther. 257 1991 870 878
215. G.D. Zeevalk W.J. Nicklas Nitric oxide in retina: Relation to excitatory amino acids and excitotoxicity Exp. Eye Res. 58 1994 343 350
216. W. Zheng S. Ren J.H. Graziano Manganese inhibits mitochondrial aconitase, a mechanism of manganese neurotoxicity Brain Res. 799 1998 334
217. L. Zou J. Xu J. Jankovic Y. He S.H. Appel W. Le Pramipexole inhibits lipid peroxidation and reduces injury in the substantia nigra induced by the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57BL/6 mice Neurosci. Lett. 281 2000 167 170